Hyperbaric oxygen as a treatment modality in cyclophosphamide-induced hemorrhagic cystitis.

Kaur, Dominder; Khan, Shakila P; Rodriguez, Vilmarie; Arndt, Carola; Claus, Paul

Kaur, Dominder; Khan, Shakila P; Rodriguez, Vilmarie; Arndt, Carola; Claus, Paul.

Affiliation

Kaur D; Division of Hematology/Oncology & BMT, Nationwide Children's Hospital, Columbus, OH, USA.
Khan SP; Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, MN, USA.
Rodriguez V; Division of Pediatric Hematology Oncology and Bone Marrow Transplantation, Mayo Clinic, Rochester, MN, USA.
Arndt C; Division of Pediatric Hematology Oncology, Mayo Clinic, Rochester, MN, USA.
Claus P; Division of Pediatric Hematology Oncology and Bone Marrow Transplantation, Mayo Clinic, Rochester, MN, USA.

Pediatr Transplant ; 22(4): e13171, 2018 06.

Article in En | MEDLINE | ID: mdl-29569791

Subject(s)

Cyclophosphamide/adverse effects; Cystitis/therapy; Hematuria/therapy; Hyperbaric Oxygenation; Immunosuppressive Agents/adverse effects; Adolescent; Adult; Cystitis/chemically induced; Female; Hematuria/chemically induced; Humans; Male

Key words

HC; HSCT; bone marrow transplant; cyclophosphamide; hyperbaric oxygen; pediatric

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cyclophosphamide / Cystitis / Hematuria / Hyperbaric Oxygenation / Immunosuppressive Agents Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Pediatr Transplant Journal subject: PEDIATRIA / TRANSPLANTE Year: 2018 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google